Login / Signup
Gemtuzumab ozogamicin in (KMT2A)-rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials.
Richard Dilon
Robert K Hills
Alan K Burnett
Nigel H Russell
Published in:
British journal of haematology (2021)
Keyphrases
</>
acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
acute lymphoblastic leukemia
liver failure
healthcare
respiratory failure
drug induced
intensive care unit
immune response
aortic dissection
mechanical ventilation
childhood cancer